Discussion about this post

User's avatar
Neural Foundry's avatar

Outstanding move positioning Próspera as the biotech fast-lane. The regulatory sandbox angle is what matters most here, letting founders test gene therapies without the usual decade-long slog. I've seen way too many promising longevty startups get crushed by compliance costs before they can even validate their thesis. Unlimited Bio going from idea to celebrity clients in under a year is the kind of timeline that fundamentally reshapes what's posible in this space.

Expand full comment

No posts

Ready for more?